Viewing Study NCT06826768


Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2026-02-03 @ 6:42 PM
Study NCT ID: NCT06826768
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-02-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords: